Corrigendum to "Advancing PICC excellence in cancer care: Integrating evidence-based practice with patient-centered outcomes" [Asia-Pac J Oncol Nurs 12 (2025) 100698]

The authors would like to make the following corrections to the published editorial1. After publication, it was brought to our attention that the reference list required revisions to ensure accuracy and alignment with the sources intended to support the editorial content. The updated reference list is provided below. Updated References: 1. Jahanzeb M, Wu C Y, Lim H J, et al. An international expert consensus on improving the quality of care in patients with cancer by optimal central vascular access device selection. J Clin Oncol. 2024;42(16_suppl):e23233–e23233. https://doi.org/10.1200/JCO.2024.42.16_suppl.e23233 2. Gorski L A. Update: The 2024 Infusion Therapy Standards of Practice. Home Healthc Now. 2024;42(4):198–205. https://doi.org/10.1097/NHH.0000000000001270 3. Parás-Bravo P, Paz-Zulueta M, Santibañez M, et al. Living with a peripherally inserted central catheter: the perspective of cancer outpatients—a qualitative study. Support Care Cancer. 2018;26(2):441–449. https://doi.org/10.1007/s00520-017-3815-4 4. O'Grady N P, Alexander M, Burns L A, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e162–e193. https://doi.org/10.1093/cid/cir257 5. Duggan C, Hernon O, Dunne R, et al. Vascular access device type for systemic anti-cancer therapies in cancer patients: A scoping review. Crit Rev Oncol Hematol. 2024;196:104277. https://doi.org/10.1016/j.critrevonc.2024.104277 The authors sincerely apologize for any inconvenience this may have caused.